The pahtway p464 has 79 genes in the original annotation. Currently, there are 59 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
| Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
| 983 | CDK1 | CDC2 | CDC28A | P34CDC2 | cyclin-dependent kinase 1 | | | 10q21.1 |
| 23411 | SIRT1 | SIR2 | SIR2L1 | SIR2alpha | sirtuin 1 | | | 10q21.3 |
| 355 | FAS | ALPS1A | APO-1 | APT1 | CD95 | FAS1 | FASTM | TNFRSF6 | Fas cell surface death receptor | | | 10q24.1 |
| 9184 | BUB3 | BUB3L | hBUB3 | BUB3 mitotic checkpoint protein | | | 10q26 |
| 7490 | WT1 | AWT1 | EWS-WT1 | GUD | NPHS4 | WAGR | WIT-2 | WT33 | Wilms tumor 1 | | | 11p13 |
| 10413 | YAP1 | COB1 | YAP | YAP2 | YAP65 | YKI | Yes associated protein 1 | | | 11q13 |
| 10524 | KAT5 | ESA1 | HTATIP | HTATIP1 | PLIP | TIP | TIP60 | ZC2HC5 | cPLA2 | lysine acetyltransferase 5 | | | 11q13 |
| 5970 | RELA | NFKB3 | p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | | | 11q13 |
| 63970 | TP53AIP1 | P53AIP1 | tumor protein p53 regulated apoptosis inducing protein 1 | | | 11q24 |
| 1111 | CHEK1 | CHK1 | checkpoint kinase 1 | | | 11q24.2 |
| 196513 | DCP1B | DCP1 | decapping mRNA 1B | | | 12p13.33 |
| 5204 | PFDN5 | MM-1 | MM1 | PFD5 | prefoldin subunit 5 | | | 12q12 |
| 6667 | SP1 | - | Sp1 transcription factor | | | 12q13.1 |
| 4193 | MDM2 | ACTFS | HDMX | hdm2 | MDM2 proto-oncogene | | | 12q14.3-q15 |
| 675 | BRCA2 | BRCC2 | BROVCA2 | FACD | FAD | FAD1 | FANCD | FANCD1 | GLM3 | PNCA2 | XRCC11 | breast cancer 2 | | | 13q12.3 |
| 5925 | RB1 | OSRC | PPP1R130 | RB | p105-Rb | pRb | pp110 | retinoblastoma 1 | | | 13q14.2 |
| 5265 | SERPINA1 | A1A | A1AT | AAT | PI | PI1 | PRO2275 | alpha1AT | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | | | 14q32.1 |
| 5371 | PML | MYL | PP8675 | RNF71 | TRIM19 | promyelocytic leukemia | | | 15q22 |
| 64782 | AEN | ISG20L1 | pp12744 | apoptosis enhancing nuclease | | | 15q26.1 |
| 5347 | PLK1 | PLK | STPK13 | polo like kinase 1 | | | 16p12.2 |
| 3029 | HAGH | GLO2 | GLX2 | GLXII | HAGH1 | hydroxyacylglutathione hydrolase | | | 16p13.3 |
| 51741 | WWOX | D16S432E | EIEE28 | FOR | FRA16D | HHCMA56 | PRO0128 | SCAR12 | SDR41C1 | WOX1 | WW domain containing oxidoreductase | | | 16q23 |
| 54894 | RNF43 | RNF124 | URCC | ring finger protein 43 | | | 17q22 |
| 2194 | FASN | FAS | OA-519 | SDR27X1 | fatty acid synthase | | | 17q25 |
| 23327 | NEDD4L | NEDD4-2 | NEDD4.2 | RSP5 | hNEDD4-2 | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase | | | 18q21.31 |
| 5300 | PIN1 | DOD | UBL5 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | | | 19p13 |
| 581 | BAX | BCL2L4 | BCL2-associated X protein | | | 19q13.3-q13.4 |
| 5567 | PRKACB | PKA C-beta | PKACB | protein kinase cAMP-activated catalytic subunit beta | | | 1p31.1 |
| 3716 | JAK1 | JAK1A | JAK1B | JTK3 | Janus kinase 1 | | | 1p32.3-p31.3 |
| 2810 | SFN | YWHAS | stratifin | | | 1p36.11 |
| 7161 | TP73 | P73 | tumor protein p73 | | | 1p36.3 |
| 10277 | UBE4B | E4 | HDNB1 | UBOX3 | UFD2 | UFD2A | ubiquitination factor E4B | | | 1p36.3 |
| 6273 | S100A2 | CAN19 | S100L | S100 calcium binding protein A2 | | | 1q21 |
| 4914 | NTRK1 | MTC | TRK | TRK1 | TRKA | Trk-A | p140-TrkA | neurotrophic tyrosine kinase, receptor, type 1 | | | 1q21-q22 |
| 8682 | PEA15 | HMAT1 | HUMMAT1H | MAT1 | MAT1H | PEA-15 | PED | phosphoprotein enriched in astrocytes 15 | | | 1q21.1 |
| 4720 | NDUFS2 | CI-49 | NADH:ubiquinone oxidoreductase core subunit S2 | | | 1q23 |
| 83737 | ITCH | ADMFD | AIF4 | AIP4 | NAPP1 | itchy E3 ubiquitin protein ligase | | | 20q11.22 |
| 100 | ADA | - | adenosine deaminase | | | 20q13.12 |
| 2033 | EP300 | KAT3B | RSTS2 | p300 | E1A binding protein p300 | | | 22q13.2 |
| 5600 | MAPK11 | P38B | P38BETA2 | PRKM11 | SAPK2 | SAPK2B | p38-2 | p38Beta | mitogen-activated protein kinase 11 | | | 22q13.33 |
| 10018 | BCL2L11 | BAM | BIM | BOD | BCL2 like 11 | | | 2q13 |
| 699 | BUB1 | BUB1A | BUB1L | hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase | | | 2q14 |
| 274 | BIN1 | AMPH2 | AMPHL | SH3P9 | bridging integrator 1 | | | 2q14 |
| 3556 | IL1RAP | C3orf13 | IL-1RAcP | IL1R3 | interleukin 1 receptor accessory protein | | | 3q28 |
| 8626 | TP63 | AIS | B(p51A) | B(p51B) | EEC3 | KET | LMS | NBP | OFC8 | RHS | SHFM4 | TP53CP | TP53L | TP73L | p40 | p51 | p53CP | p63 | p73H | p73L | tumor protein p63 | | | 3q28 |
| 200933 | FBXO45 | Fbx45 | F-box protein 45 | | | 3q29 |
| 174 | AFP | AFPD | FETA | HPAFP | alpha fetoprotein | | | 4q13.3 |
| 1026 | CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A | | | 6p21.2 |
| 578 | BAK1 | BAK | BAK-LIKE | BCL2L7 | CDN1 | BCL2 antagonist/killer 1 | | | 6p21.3 |
| 1432 | MAPK14 | CSBP | CSBP1 | CSBP2 | CSPB1 | EXIP | Mxi2 | PRKM14 | PRKM15 | RK | SAPK2A | p38 | p38ALPHA | mitogen-activated protein kinase 14 | | | 6p21.3-p21.2 |
| 2309 | FOXO3 | AF6q21 | FKHRL1 | FKHRL1P2 | FOXO2 | FOXO3A | forkhead box O3 | | | 6q21 |
| 23493 | HEY2 | CHF1 | GRIDLOCK | GRL | HERP1 | HESR2 | HRT2 | bHLHb32 | hes related family bHLH transcription factor with YRPW motif 2 | | | 6q21 |
| 1021 | CDK6 | MCPH12 | PLSTIRE | cyclin-dependent kinase 6 | | | 7q21-q22 |
| 5054 | SERPINE1 | PAI | PAI-1 | PAI1 | PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | | | 7q22.1 |
| 835 | CASP2 | CASP-2 | ICH1 | NEDD-2 | NEDD2 | PPP1R57 | caspase 2 | | | 7q34-q35 |
| 9134 | CCNE2 | CYCE2 | cyclin E2 | | | 8q22.1 |
| 4609 | MYC | MRTL | MYCC | bHLHe39 | c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | | | 8q24.21 |
| 3297 | HSF1 | HSTF1 | heat shock transcription factor 1 | | | 8q24.3 |
| 25 | ABL1 | ABL | JTK7 | bcr/abl | c-ABL | c-ABL1 | p150 | v-abl | ABL proto-oncogene 1, non-receptor tyrosine kinase | | | 9q34.1 |